RecoverySupplement GuideJun 2026

The Wolverine Stack: BPC-157 + TB-500

The Wolverine stack pairs two recovery peptides, BPC-157 and TB-500, named for the fast-healing comic character. The idea is simple: the two work through different mechanisms, so combining them targets tissue repair from two angles at once. Here is what each does, why they are stacked, and how people run it.

What the Stack Is

The Wolverine stack is just two peptides run together: BPC-157 and TB-500. Both are studied for tissue repair and recovery, and the nickname comes from the comic character whose defining trait is healing fast.

The logic behind pairing them is that they work through different pathways. Rather than doubling up on one mechanism, you cover two, which is why the combination has become the go-to recovery stack in the peptide community.

How They Work Together

BPC-157

A peptide studied for localized healing, especially tendon, ligament, gut, and joint tissue. Often injected near the injury. Associated with angiogenesis, the growth of new blood vessels that feed repair.

TB-500

A synthetic version of a fragment of thymosin beta-4, studied for systemic repair, cell migration, and flexibility. Used body-wide rather than at one spot, so it complements BPC-157’s local action.

The pairing is complementary: BPC-157 is often aimed at a specific injury, while TB-500 works across the whole system. Together they are intended to cover both targeted and general recovery. Note that most of the supporting evidence is preclinical, so this is a mechanism-based rationale, not a settled clinical conclusion.

How People Run It

Every figure below is community practice. No clinical trial has established a human dose for either compound, neither is approved in any market, so there is no label to cite, and the numbers people repeat trace back to forums and coaches rather than to evidence. They are published here with that label attached, not as instruction.

Peptide	Reported dose	Reported frequency	Source tier
BPC-157	250 to 500 mcg	Daily, often near the injury	Community practice, no trial
TB-500	2 to 5 mg	Weekly, often split into 2 doses, systemic	Community practice, no trial

Reported cycles run 4 to 8 weeks, and front-loading TB-500 at the higher end before dropping to a lower amount is a common pattern (community practice, no trial). The only published dosing figures for either compound are from animals: a rat Achilles tendon study used BPC-157 at 10 mcg, 10 ng or 10 pg per kg body weight intraperitoneally once daily (rat study, not a human dose, PMID 14554208). Full per-compound detail is on the BPC-157 and TB-500 pages.

What To Expect

Reported outcomes center on faster recovery from soft-tissue injuries, reduced joint and tendon discomfort, and improved mobility over a 4 to 8 week cycle (community practice, no trial). The strongest anecdotes come from people dealing with nagging tendon or ligament issues that were slow to heal on their own, which is also the situation where an injury is most likely to improve on its own timeline regardless.

Set expectations realistically: the human evidence is limited and most data is preclinical. These peptides support recovery; they do not replace rest, rehab, physiotherapy, or proper load management. They are best thought of as one input alongside the basics, not a shortcut around them.

Sourcing and Quality

With research peptides, quality is the whole game. Underdosed or impure product is the most common reason a stack does nothing. Look for a third-party Certificate of Analysis per batch, cold-chain shipping (peptides degrade in heat, which matters in Vietnam), and a supplier you can actually reach with questions.

Peptara Labs

peptaralabs.io

Third-party COA per batch

Cold-chain delivery nationwide

BPC-157 + TB-500 in stock

WhatsApp + Zalo support

Peptara Labs is our trusted supply partner. We may earn from purchases made through our links.

Visit Peptara Labs

The Short Version

The Wolverine stack is BPC-157 plus TB-500, run together for recovery.

BPC-157 acts locally (often near the injury); TB-500 works systemically.

Reported ranges: BPC-157 250 to 500 mcg daily, TB-500 2 to 5 mg weekly, 4 to 8 week cycles (community practice, no trial: no clinical trial has set a human dose and neither compound has an approved label).

Reported benefits center on soft-tissue and tendon recovery.

Evidence is mostly preclinical. It supports recovery, it does not replace rehab.

Quality is everything: insist on a per-batch COA and cold-chain shipping.

Frequently Asked Questions

What is the Wolverine stack?

The Wolverine stack is the combination of two recovery peptides, BPC-157 and TB-500, run together for injury recovery and tissue repair. It is named after the comic character known for rapid healing. The two are paired because they support repair through different mechanisms, so the combination is thought to be more complete than either alone.

What is the dosing for BPC-157 and TB-500 together?

Community practice reports: BPC-157 at 250 to 500 mcg daily, often near the injury site, and TB-500 at 2 to 5 mg per week, often split into two doses and given systemically, over a 4 to 8 week cycle (community practice, no trial). Disclaimer: No clinical trial has established that or any other human dose for BPC-157 or TB-500. Neither is approved in any market, so there is no label to cite either. That does not make these numbers wrong. It does mean nobody has measured what happens at these levels in humans over time. The nearest published figures are from animals: a rat Achilles tendon study gave BPC-157 at 10 mcg, 10 ng or 10 pg per kg body weight intraperitoneally once daily (PMID 14554208), which is a rat dose and not a human one.

How long does the Wolverine stack take to work?

Community practice reports: Noticeable improvement over a 4 to 8 week cycle, with some accounts describing relief earlier than that (community practice, no trial). Disclaimer: no controlled human trial has measured a recovery timeline for BPC-157 or TB-500, alone or combined, so there is nothing clinical to hold that range against. Self-reported timelines are not evidence of a timeline: injuries improve on their own, rehabilitation drives most of the recovery, and neither is separable from a peptide inside an anecdote. The published work on both compounds is preclinical, and a healing curve in a rat tendon is not a schedule for a person.

Is the Wolverine stack safe?

BPC-157 and TB-500 are research peptides, not approved medications, and long-term human safety data is limited. Most reported side effects are mild, but the honest position is that the evidence base is thinner than for approved drugs. Quality of the product matters a lot, and anyone considering them should consult a healthcare professional first.

Not medical advice. Consult a healthcare professional before starting any supplement or protocol.